Free shipping on all orders over $ 500

PLK Polo-like kinase

Inhibitors

Cat.No.  Name Information
M1672 BI 2536 BI 2536 is a novel, highly selective, potent dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively.
M13721 TAK-960 dihydrochloride TAK-960 dihydrochloride is an orally available, selective inhibitor of polo-like kinase 1 (PLK1), with an IC50 of 0.8 nM.
M13720 Rigosertib sodium Rigosertib sodium (ON-01910 sodium) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3K/Akt pathway, promotes the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle.
M13719 Rigosertib Rigosertib (ON-01910) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3 kinase/Akt pathway, promots the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle.
M13718 Onvansertib NMS-1286937 is a potent, selective and orally available PLK1 inhibitor, with an IC50 of 2 nM.
M13717 HMN-214 HMN-214, an orally bioavailable prodrug of HMN-176, is an inhibitor of polo-like kinase-1 (plk1), with antitumor activity.
M9307 TC-S 7005 TC-S 7005 is a potent and selective polo-like kinase 2 (PLK2) inhibitor (IC50 = 4 nM).
M9250 HMN-176 HMN-176 inhibits mitosis, interfering with polo-like kinase-1 (plk1), without significant effect on tubulin polymerization.
M8519 Mps1-IN-2 Mps1-IN-2 is a potent and selective inhibitor of Mps1 kinase.
M7559 ON1231320 ON1231320, also known as GBO-006, is a Polo-like kinase 2 (PLK2) inhibitor. In vitro testing revealed that ON1231320 is a selective inhibitor of PLK2 with no inhibitory activity against PLK1, PLK3 and PLK4.
M7271 SBE13 hydrochloride SBE13 hydrochloride is a potent and selective PLK1 inhibitor.
M3293 HMN-214 HMN-214 is a procompound of HMN-176, which alters the cellular spatial orientation of Plk1.
M3198 TAK-960 TAK-960 is a novel, potent and selective Plk1 inhibitor with IC50 of 8 nM.
M2983 Ro3280 RO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1) with IC50 of 3 nM.
M2860 MLN0905 MLN0905 is a potent inhibitor of PLK1 with IC50 of 2 nM.
M2741 GW843682X GW 843682X is a PLK inhibitor for PLK1 and PLK3 with IC50 of 2.2 nM and 9.1 nM, respectively.
M2211 Rigosertib sodium Rigosertib sodium is a dual non-ATP inhibitor of polo-like kinase 1 (Plk1) and phosphoinositide 3-kinase pathways (PI3K).
M1719 GSK461364 GSK461364 is a potent and selective small molecule inhibitor of Polo-like kinase 1 (PLK1) with a Ki of 2.2 nM.
M1678 BI 6727 BI 6727 (Volasertib) is a small highly potent Polo-like kinase inhibitor (Plk1) with an IC50 of 0 .87 nM.
M1672 BI 2536 BI 2536 is a novel, highly selective, potent dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively.



Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.